Delivery Order SPE2DB22D1202-SPE2DB24FVJD7
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $23,104.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of February 28, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award, valued at $152,581.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of...
This federal contract award, valued at $53,244.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $14,270.52 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET medication, with a completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its extensive work providing a wide range of prescription drugs, medical supplies, and equipment to support...
This federal contract award, valued at $145,888.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of September 11, 2024. This award is not associated with a set-aside program. As a significant supplier of medical commodities to federal agencies,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,743.80, is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET 30 count. The contract has a firm fixed price and has a completion date of May 21, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $17,456.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of June 7, 2024 and is a Firm Fixed Price arrangement. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $11,529.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BIKTARVY 30-120-15 MG TABLET 30S, a prescription medication. This is a Delivery Order contract with a Firm Fixed Price pricing type. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen Drug Corp is the prime contractor, with no set-aside designation indicated. The...
This federal contract award, valued at $7,882.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with an ultimate completion date of August 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation. As one of the largest pharmaceutical distributors in the U.S.,...
This federal contract award is a delivery order valued at $4,751.24 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, with a period of performance ending on August 5, 2024. The contract does not have any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...